Gain Therapeutics

Gain Therapeutics

Biotechnology Research Ch 31 employees
Employees
31
Contacts
4
Emails
4
Phones
2

Gain Therapeutics Overview

Headquarters
Ch
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
31
Founded
2017
Funding
7.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Gain Therapeutics

Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being evaluated for the treatment of Parkinson’s disease with or without a GBA1 mutation. Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma exposure in the projected therapeutic range, CNS exposure, and target engagement and modulation of GCase enzyme. Gain’s unique approach enables the discovery of novel, allosteric small molecule modulators that can restore or disrupt protein function. Deploying its highly advanced Magellan™ platform, Gain is accelerating drug discovery and unlocking novel disease-modifying treatments for untreatable or difficult-to-treat disorders including neurodegenerative diseases, rare genetic disorders and oncology.

Gain Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Gain Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Gwen Melincoff
Email Phone
Joanne Taylor SVP Research at Gain Therapeutics
Email
Jonas H. CMO Gain Therapeutics
Email Phone
Lorenzo Leoni Scientific Serial Entrepreneur
Email

Employees by Management Level

Individual contributor 6 profiles
Associate / junior 2 profiles
Executive 1 profile
VP / Head 1 profile
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 0

Gain Therapeutics Tech Stack

Data / AI 1 profile
Engineering 1 profile

Compare Similar Companies to Gain Therapeutics